share_log

Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

Benzinga ·  Mar 15, 2023 20:44

Gainers

  • Jounce Therapeutics, Inc. (NASDAQ:JNCE) shares rose 36.8% to $1.45 in pre-market after the company confirmed receipt of unsolicited proposal from Concentra Biosciences to acquire 100% of the company for $1.80 per share subject to diligence and availability of at least $130m of cash and equivalents at closing.
  • HUB Cyber Security (Israel) Ltd. (NASDAQ:HUBC) rose 15.5% to $1.93 in pre-market trading after gaining more than 10% on Tuesday. HUB Security received $4 million from PIPE Investors at $10 per share.
  • NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) rose 15.2% to $1.81 in pre-market trading after gaining around 5% on Tuesday.
  • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) rose 14.1% to $3.49 in pre-market trading.
  • Loyalty Ventures Inc. (NASDAQ:LYLT) rose 13.2% to $0.1924 in pre-market trading after dipping 23% on Tuesday.
  • Smartsheet Inc. (NYSE:SMAR) rose 11.2% to $42.61 in pre-market trading after the company reported better-than-expected Q4 results and issued strong EPS guidance.
  • Ambipar Emergency Response (NYSE:AMBI) rose 10.5% to $13.54 in pre-market trading after jumping around 117% on Tuesday.
  • Elevation Oncology, Inc. (NASDAQ:ELEV) rose 9.8% to $1.57 in pre-market trading after jumping around 29% on Tuesday.
  • Kingsoft Cloud Holdings Limited (NASDAQ:KC) rose 8.6% to $4.43 in pre-market trading.

Losers

  • Inpixon (NASDAQ:INPX) fell 41.9% to $0.41 in pre-market. Inpixon completed distribution and business combination of CXApp Holding Corp. with KINS Technology Group Inc.
  • Boxed, Inc. (NYSE:BOXD) fell 38.8% to $0.26 in pre-market trading. Boxed is negotiating with lenders for bankruptcy sale, the Wall Street Journal reported.
  • Celyad Oncology SA (NASDAQ:CYAD) shares fell 25.1% to $0.7199 in pre-market trading. Celyad Oncology booked €35.1 million in goodwill and intangible impairment in FY22.
  • Credit Suisse Group AG (NYSE:CS) fell 22.3% to $1.95 in pre-market trading. Saudi Arabia's SNB said it cannot give more money to Credit Suisse because cannot go above 10% ownership due to regulatory issue.
  • Intelligent Bio Solutions Inc. (NASDAQ:INBS) fell 19.5% to $2.21 in pre-market trading. Intelligent Bio Solutions recently announced pricing of a $2.2 million public offering.
  • Vacasa, Inc. (NASDAQ:VCSA) fell 13.7% to $1.13 in pre-market trading after reporting Q4 results.
  • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) fell 12.1% to $0.4607 in pre-market trading. Quoin Pharmaceuticals recently posted a Q4 loss of $0.41 per share.
  • Elys Game Technology, Corp. (NASDAQ:ELYS) shares dropped 10.5% to $0.51 in pre-market trading after surging 33% on Tuesday.
  • Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) fell 10.3% to $10.50 in pre-market trading. Merrimack Pharmaceuticals recently posted a FY22 loss of $0.11 per share.
  • Lannett Company, Inc. (NYSE:LCI) shares fell 10.1% to $1.60 in pre-market trading after declining over 4% on Tuesday. Lannett recently posted upbeat Q2 results.

Now Read This: Adobe Likely To Report Higher Quarterly Earnings - Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment